Hypoxia decreases invasin-mediated yersinia enterocolitica internalization into Caco-2 Cells

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Zeitouni, Nathalie E ^a   Dersch, Petra ^a   Naim, Hassan Y ^b   Von Köckritz Blickwede, Maren ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FOCAL ADHESION KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INVASIN; ADHESIN; INVASIN, YERSINIA; OXYGEN;

ARTICLE; CACO 2 CELL LINE; CELL HYPOXIA; CELL INVASION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PROTEIN PHOSPHORYLATION; YERSINIA ENTEROCOLITICA; CACO-2 CELL LINE; HYPOXIA; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; YERSINIA INFECTION;

ADHESINS, BACTERIAL; ANTIGENS, CD29; CACO-2 CELLS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; HYPOXIA; INTESTINAL MUCOSA; OXYGEN; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 84953911638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146103     Document Type: Article

References (94)

1. Taylor CT, Colgan SP: Hypoxia and gastrointestinal disease. J Mol Med 2007; 85:1295-1300.
2. Carreau A, Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C: Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 2011; 15:1239-53. doi: 10. 1111/j.1582-4934.2011.01258.x
3. Glover L, Colgan S: Hypoxia and Metabolic Factors That influence inflammatory bowel disease pathogenesis. Gastroenterology 2011; 140:1748-1755. doi: 10.1053/j.gastro.2011.01.056
4. Melican K, Boekel J, Mansson L, Sandoval R, Tanner G, Källskog O, et al. Bacterial infection-mediated mucosal signalling induces local renal ischaemia as a defence against sepsis. Cellular Microbiol 2008; doi: 10.1111/j.1462-5822.2008.01182.x
5. Bhandari T, Nizet V: Hypoxia-inducible factor (HIF) as a pharmacological target for prevention and treatment of infectious diseases. Infect Dis Ther 2014; 3:159-174
6. Zinkernagel A, Johnson R, Nizet V: Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med 2007; 85:1339-1346.
7. Bouvry D, Planes C, Malbert-Colas L, Escabasse V, Clerici C: Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells. Am J Respir Cell Mol Biol 2006; 35:519-527.
8. Botto L, Beretta E, Bulbarelli A, Rivolta I, Lettiero B, Leone BE, et al. Hypoxia induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells. J Cell Biochem 2008; 105:503-513. doi: 10.1002/jcb.21850
9. Bottone E: Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997; 10:257-76.
10. Bottone EJ, Chester B, Malowany MS, Allerhand J: Unusual Yersinia enterocolitica isolates not associated with mesenteric lymphadenitis. Appl Microbiol 1974 May 3; 27:858-61.
11. Reis R, Horn F: Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases. Gut Pathog 2010; 2:2-12
12. Hanski Naumann, Hahn Riecken: Determinants of invasion and survival of Yersinia enterocolitica in intestinal tissue. Med Microbiol Immunol 1988; doi: 10.1007/BF00191063
13. Grutzkau A, Hanski C, Hahn H, Riecken EO: Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 1990; 31:1011-1015.
14. Clark AM, Hirst BH, Jepson MA: M-cell surface 1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun 1998; 66:1237-1243.
15. Isberg RR, Voorhis DL, Falkow S: Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 1987 5; 50:769-78.
16. Isberg RR, Falkow S: A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 1985 2; 317:262-4.
17. Miller VL, Finlay BB, Falkow S: Factors essential for the penetration of mammalian cells by Yersinia. Curr Top Microbiol Immunol 1988 5; 138:15-39.
18. Young Miller, Falkow Schoolnik: Sequence, localization and function of the invasin protein of Yersinia enterocoiitica. Molecul Microbiol 1990; 4:1119-1128
19. Eitel J, Dersch P: The YadA protein of Yersinia pseudotuberculosis mediates high-efficiency uptake into human cells under environmental conditions in which invasin is repressed. Infect Immun 2002 1; 70:4880-91.
20. Miller VL, Falkow S: Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect Immun 1988 2; 56:1242-8.
21. Isberg RR, Leong JM: Multiple 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990; 60:861-871.
22. Nhieu GT Van, Isberg RR: The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the alpha 5 beta 1 integrin receptor. J Biol Chem 1991 3; 266:24367-75.
23. Srichai MB, Pozzi A: Integrin Structure and Function. In Zent R. and Pozzi A. ed. Cell-extracellular matrix interactions in cancer. Springer Science p 19-41. 2010, pp 19-41
24. Hynes RO: Integrins: Bidirectional, allosteric signaling machines. Cell 2002; 110:673-687.
25. Schwartz MA, Schaller MD, Ginsberg MH: Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995; 11:549-99.
26. Dersch P, Isberg R: A region of the Yersinia pseudotuberculosis invasin protein enhances integrinmediated uptake into mammalian cells and promotes self-Association. EMBO J 1999; 18:1199-1213.
27. Alrutz MA, Isberg RR: Involvement of focal adhesion kinase in invasin-mediated uptake. PNAS 1998; doi: 10.1073/pnas.95.23.13658
28. Wong KW, Isberg RR: Yersinia pseudotuberculosis spatially controls activation and misregulation of host cell Rac1. Plos Pathog 2005; doi: 10.1371/journal.ppat.0010016
29. Fogh J, Fogh JM, Orfeo T: One hundred and twenty-seven cultured human tumor cel lines producing tumors in nude mice. J Natl Cancer Inst 1977; 59:221-226.
30. Pepe J, Badger J, Miller V: Growth phase and low pH affect the thermal regulation of the Yersinia enterocolitica inv gene. Mol Microbiol 1994; 11:123-135.
31. Uliczka F, Pisano F, Schaake J, Stolz T, Rohde M, Fruth A, et al. Unique cell adhesion and invasion properties of yersinia enterocolitica O:3, the most frequent cause of human yersiniosis. PLoS Pathog. 2011; 7. doi: 10.1371/journal.ppat.1002117
32. Schmitz J, Preiser H, Maestracci D, Ghosh BK, Cerda JJ, Crane RK. Purification of the human intestinal brush border membrane. Biochim Biophys Acta-Biomembranes. 1973; 323(1):98-112
33. Hein Z, Schmidt S, Zimmer K-P, Naim H (2011) The dual role of annexin II in targeting of brush border proteins and in intestinal cell polarity. Differentiation 81: 243252. doi: 10.1016/j.diff.2011.01.009
34. Pinto M, Robine-Leon S, Appay M-DC, Kedinger M, Triadou N, Dussaulx E, et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 1983; 47:323-330
35. Zweibaum A, Triadou N, Kedinger M, Augeron C, Robine-Léon S, Pinto M, et al. Sucrase-isomaltase: A marker of foetal and malignant epithelial cells of the human colon. Int J Cancer 1983; 32:407-412.
36. Tafazoli F, Holmstrm A, Forsberg , Magnusson K-E: Apically exposed, tight junction-Associated 1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia Bacteria. Infect Immun 2000; 68:5335-5343.
37. Vanderkooi JM, Maniara G, Green TJ, Wilson DF: An optical method for measurement of dioxygen concentration based upon quenching of phosphorescence. J Biol Chem 1987; 262:5476-82.
38. Mandell GL: Interaction of Intraleukocytic Bacteria and Antibiotics. J Clin Invest 1973; 52:1673-9.
39. Alrutz M a, Isberg RR. Involvement of focal adhesion kinase in invasin-mediated uptake. Proc Natl Acad Sci U S A. 1998; 95: 13658-63. doi: 10.1073/pnas.95.23.13658
40. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol. 1994 2; 14 (3):1680-8.
41. Guan J-L. Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 1997 29: 1085-1096. doi: 10.1016/S1357-2725(97)00051-4
42. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12:5447-54.
43. Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292:468-472.
44. Beaulieu JF: Differential expression of the VLA family of integrins along the crypt-villus axis in the human small intestine. J Cell Sci 1992; 102 (3):427-36
45. Hamzaoui N, Kernéis S, Caliot E, Pringault E: Expression and distribution of beta1 integrins in in vitroinduced M cells: implications for Yersinia adhesion to Peyer's patch epithelium. Cell Microbiol 2004 3; 6:817-28.
46. Curfs J, Meis J, Fransen J, Lee H, Hoogkamp-Korstanje J: Interactions of Yersinia enterocolitica with polarized human intestinal Caco-2 cells. Med Microbiol Immunol 1995; 184. doi: 10.1007/BF00224348
47. Trier JS, Madara JL: Morphology of mucosa of small intestine. New York, Raven Press, 1988, p 953-955
48. Giannasca PJ, Giannasca KT, Leichtner AM, Neutra MR: Human intestinal M cells display the sialyl Lewis A antigen. Infect Immun 1999; 67:946-53.
49. Finlay B, Falkow S: Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 1988; 70:1089-1099.
50. Coconnier MH, Bernet-Camard MF, Servin AL: How intestinal epithelial cell differentiation inhibits the cell-entry of Yersinia pseudotuberculosis in colon carcinoma Caco-2 cell line in culture. Differentiation 1994 2; 58:87-94.
51. Vachon PH, Beaulieu JF: Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology 1992 Aug 6; 103:414-23.
52. Vachon P, Perreault N, Magny P, Beaulieu J: Uncoordinated, transient mosaic patterns of intestinal hydrolase expression in differentiating human enterocytes. J Cell Physiol 1996; 166:198-207.
53. Schreider C, Peignon G, Thenet S, Chambaz J, Pincon-Raymond M: Integrin-mediated functional polarization of Caco-2 cells through E-cadherin-Actin complexes. J Cell Sci 2002; 115:543-52.
54. Kaiserlian D, Rigal D, Abello J, Revillard JP: Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol 1991; 21:2415-21.
55. Vachon PH, Durand J, Beaulieu JF: Basement membrane formation and re-distribution of the beta 1 integrins in a human intestinal co-culture system. Anat Rec 1993; 235:567-76.
56. Gaillard JL, Finlay BB: Effect of cell polarization and differentiation on entry of Listeria monocytogenes into the enterocyte-like Caco-2 cell line. Infect Immun 1996; Available from: http://iai.asm.org/content/64/4/1299
57. Pereira SH, Cervante MP, Bentzmann S, Plotkowski MC: Pseudomonas aeruginosa entry into Caco-2 cells is enhanced in repairing wounded monolayers. Microb Pathog 1997; 23:249-55.
58. Miller VL, Bliska JB, Falkow S: Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product. J Bacteriol 1990; 172:1062-1069.
59. Bliska JB, Copass MC, Falkow S: The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells. Infect Immun 1993; 61:3914-21.
60. Pepe JC, Wachtel MR, Wagar E: Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun 1995; Available from: http://iai.asm.org/content/63/12/4837
61. Colgan SP, Curtis VF, Campbell EL: The inflammatory tissue microenvironment in IBD. Inflamm Bowel Dis 2013; 19:2238-2244. doi: 10.1097/MIB.0b013e31828dcaaf
62. Hatoum OA, Binion DG, Gutterman DD: Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest 2005; 35:599-609.
63. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Medic 2001; 193:1027-1034
64. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. PNAS 1995; 92:5510-5514.
65. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15:551-78.
66. Bruick RK, McKnight SL: A Conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294:1337-1340.
67. Lee J-W, Bae S-H, Jeong J-W, Kim S-H, Kim K-W: Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions. Exp Mol Med 2004; 36:112
68. Fraisl P, Aragonés J, Carmeliet P: Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 2009; 8:139-52. doi: 10.1038/nrd2761
69. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke JJ, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107:43-54.
70. Kallio P, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. PNAS 1997; 94:5667-5672.
71. Maxwell P, Wiesener M, Chang G-W, Clifford S, Vaux E, Cockman M, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors foroxygen-dependent proteolysis. Nature 1999; 399:271-275.
72. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE: Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. PNAS 1991; 88:5680-5684.
73. Fandrey J: Hypoxia-inducible gene expression. Respir Physiol 1995; 101:1-10.
74. Wang GL, Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. PNAS 1993; 90:4304-4308.
75. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-32.
76. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt K-U, Talks KL, et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1. Blood 1998; 92:2260-2268.
77. Keely S, Glover L, MacManus C, Campbell E, Scully M, Furuta G, et al. Selective induction of integrin 1 by hypoxia-inducible factor: implications for wound healing. FASEB J 2009; 23:1338-1346. doi: 10. 1096/fj.08-125344
78. Rana M, Srivastava J, Yang M, Chen C, Barber D: Hypoxia increases the abundance but not the assembly of extracellular fibronectin during epithelial cell transdifferentiation. J Cell Sci 2015; 128:1083-9. doi: 10.1242/jcs.155036
79. Ren Y, Hao P, Law SK, Sze SK: Hypoxia-induced changes to integrin α 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431. Mol Cell Proteomics : MCP 2014; 13:3126-37. doi: 10. 1074/mcp.M114.038505
80. Yu B, Li S, Yao Y, Lin Z: Changes in beta(1) integrin in renal tubular epithelial cells after intrauterine asphyxia of rabbit pups. Journal of perinatal medicine 2009; 37:59-65. doi: 10.1515/JPM.2009.009
81. Saido TC, Sorimachi H, Suzuki K: Calpain: new perspectives in molecular diversity and physiologicalpathological involvement. FASEB J 1994; 8:814-22.
82. Wilson PD, Hartz PA: Mechanisms of cyclosporine A toxicity in defined cultures of renal tubule epithelia: a role for cysteine proteases. Cell Biol Int Rep 1991; 15:1243-58.
83. Zuk A, Bonventre JV, Brown D, Matlin KS: Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney. Am J Physiol 1998; 275:C711-31
84. Aoyama K, Ozaki Y, Nakanishi T, Ogasawara M, Ikuta K, Aoki K, et al. Cleavage of integrin by mu-calpain during hypoxia in human endometrial cells. Am J Rep Immunol 2004; 52:362-9
85. Brown DA, London E: Structure and Function of Sphingolipid-And Cholesterol-rich Membrane Rafts. J Biol Chem 2000; 275:17221-4.
86. Lindner R, Naim H: Domains in biological membranes. Exp Cell Res 2009; 315:2871-8. doi: 10.1016/j. yexcr.2009.07.020
87. Cummins EP, Taylor CT: Hypoxia-responsive transcription factors. Pflugers Archiv : Eur J Physiol 2005; 450:363-71
88. Haase VH: Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis. Ann N Y Acad Sci 2009; 1177:57-65. doi: 10.1111/j.1749-6632.2009.05030.x
89. Schaffer K, Taylor C: The impact of hypoxia on bacterial infection. FEBS J 2015; 282:2260-2266. doi: 10.1111/febs.13270
90. Lima C, Santos S dos, Junior D de, Lima C, Santos S dos, Junior D de: Hypoxic stress, hepatocytes and Caco-2 viability and susceptibility to Shigella flexneri invasion. Rev Inst Med Trop Sao Paulo 2013; 55. doi: 10.1590/S0036-46652013000500008
91. Schaible B, McClean S, Selfridge A, Broquet A, Asehnoune K, Taylor C, et al. Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS ONE 2013; 8: e56491. doi: 10.1371/journal. pone.0056491
92. Okumura CY, Hollands A, Tran DN, Olson J, Dahesh S, von KOckritz-Blickwede M, et al. A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J Mol Med 2012; 90:1079-89. doi: 10.1007/s00109-012-0882-3
93. Keely S, Campbell EL, Baird AW, Hansbro PM, Shalwitz RA, Kotsakis A, et al. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal Immunol 2014; 7:114-123. doi: 10.1038/mi.2013.29
94. Zinkernagel A, Peyssonnaux C, Johnson R, Nizet V. Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J Infect Dis 2008; 197:214-7. doi: 10.1086/524843